Trials / Completed
CompletedNCT01370837
Neurogenic Inflammation in Diabetes
Neurogenic Inflammation in Diabetic Polyneuropathy and Charcot Neuro-osteoarthropathy: Response to Intracutaneous Candida Albicans
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Maastricht University Medical Center · Academic / Other
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Polyneuropathy is a complication of diabetes mellitus which leads to decreased sensation in arms and legs. This in turn can lead to the development of (infected) foot ulcers. Charcot's disease can also be a consequence of polyneuropathy. Patients with Charcot's disease suddenly develop a red, warm and swollen foot, like an infection. Charcot's disease leads to foot fractures. After these fractures have healed, the shape of the foot can be dramatically altered. This altered shape of the foot increases the risk of developing foot ulcers. Nerves are important in regulating the inflammatory response. This study aims to investigate whether the inflammatory response is different in patients with polyneuropathy with and without a history of Charcot's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Intracutaneous injection of Candida albicans antigen. | Intracutaneous injection of 0.05 ml of four different concentrations of Candida albicans antigen on both the arm and foot. |
| OTHER | Temperature measurement. | Temperature measurement at the site of injection of the highest concentration of Candida albicans antigen on the foot and the same location on the contralateral foot using an infrared thermometer. |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2015-01-01
- Completion
- 2015-01-01
- First posted
- 2011-06-10
- Last updated
- 2015-05-06
- Results posted
- 2015-04-10
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01370837. Inclusion in this directory is not an endorsement.